Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

FDA recommendation regarding use in children
The FDA today recommended that over-the-counter (OTC) cough and cold medicines should not be used in children under 2 years of age due to the potential for serious and potentially life-threatening side effects. This recommendation was based on reports of serious side effects made to the FDA and a public advisory committee meeting held in October last year. According to today's announcement, the FDA is still conducting a review regarding the safety of these medicines for children 2 through 11 years of age. For more information, please visit: http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm048682.htm
Learn More

FDA Communication Regarding Musculoskeletal Pain
The FDA today issued a statement regarding the possibility of severe bone, joint and/or muscle pain in patients taking bisphosphonates such as { drug_name }. This pain can occur within days, months or years after starting treatment, and seems to get better if treatment is temporarily or permanently discontinued. Although this possibility is included in the prescribing information for these products, it is apparently often overlooked by healthcare professionals, delaying diagnosis and unnecessarily prolonging the problem for patients. For more information, please visit: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm101551.htm
Learn More

Date Published Title Drug Source
2008-01-17 FDA recommendation regarding use in children Pseudoephedrine FDA
2008-01-07 FDA Communication Regarding Musculoskeletal Pain Alendronate FDA
2008-01-07 FDA Communication Regarding Musculoskeletal Pain Alendronate and Vitamin D FDA
2008-01-07 FDA Communication Regarding Musculoskeletal Pain Tiludronic Acid FDA
2008-01-07 FDA Communication Regarding Musculoskeletal Pain Etidronic Acid FDA
2008-01-07 FDA Communication Regarding Musculoskeletal Pain Ibandronate Sodium FDA
2008-01-07 FDA Communication Regarding Musculoskeletal Pain Risedronic Acid FDA
2008-01-07 FDA Communication Regarding Musculoskeletal Pain Actonel Plus Calcium FDA
2008-01-03 FDA Communication Regarding Thyroid Medication Levothyroxine FDA
2008-01-03 FDA Communication Regarding Thyroid Medication Thyroid FDA
2008-01-03 FDA Communication Regarding New Anemia Drug Studies FDA
2008-01-03 FDA Communication Regarding New Anemia Drug Studies Darbepoetin Alfa FDA
2007-12-21 Drug information update on Fentanyl Transdermal System (marketed as Duragesic) Fentanyl FDA
2007-12-18 Recall of selected 180mg and 240mg bottles Thyroid FDA
2007-12-18 Recall of selected 5mg tablets Glyburide FDA
2007-12-04 Revised prescribing information regarding severe hyponatremia and seizures Desmopressin FDA
2007-11-27 Revised pregnancy rating Mycophenolate FDA
2007-11-20 FDA reviewing cases of suicidal ideation and occasional suicidal behavior Varenicline FDA
2007-11-16 Voluntary recall of 600mg and 800mg tablets Gabapentin Manufacturer
2007-11-14 New additions to black box warning Rosiglitazone FDA
Back to Consumer Med Safety